Commentary: screening for anti-cancer agents; the relative merits of in vitro and in vovo techniques.
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001215:Asparaginase / Q000627:therapeutic use; D002460:Cell Line; D004195:Disease Models, Animal; D004353:Drug Evaluation, Preclinical / Q000379:methods*; D006801:Humans; D007700:Kinetics; D009368:Neoplasm Transplantation; D009369:Neoplasms / Q000378:metabolism / Q000503:physiopathology; D009374:Neoplasms, Experimental / Q000188:drug therapy; D014183:Transplantation, Heterologous; D014184:Transplantation, Homologous
D000970:Antineoplastic Agents; D001215:Asparaginase